Skip to main content
Caplight Logo









Arincare

Arincare

Private
BangkokHealthcare & Life Scienceshttps://arincare.com/

Last Round

Series B

Extension

Jun 3, 2026

Total Funding Raised

$4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Arincare is a healthtech company that provides a digital pharmacy management platform and ecosystem for pharmacists and drugstores in Thailand.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Telemedicine, Vertical SaaS, Point-of-Sale, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Marketplace Commission, Services & Consulting, Freemium

AI Layer

Application

Keywords

pharmacy management systempharmacy softwareB2B marketplacetelehealthpoint-of-salePOSe-pharmacypharmaceutical supply chaine-prescriptionvertical SaaShealthtechinventory managementhealthcare analyticsdigital pharmacypharma procurement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arincare Comparables

Compare Arincare with similar companies based on industry and business-model similarity.

Arincare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SwipeRx
80%
mPharma
78%
PharmCare Group
67%

Arincare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJun 3, 2026
Series BJan 6, 2023
Series ANov 10, 2020
AcceleratorSep 6, 2019

Key People

Founding team and executive leadership

Teera Kanokkanjanarat

CEO & Co-Founder

Founding Team

Chaiphong Niyomkij

CFO

Executive Team

Arincare Investors

Notable investors and investment history

Arincare investors
InvestorRounds
Nexter VenturesSeries A
Dtac AccelerateAccelerator
InnoSpace (Thailand)Series B Extension
Taiwania Hive VenturesSeries B Extension
Digital Economy Promotion AgencySeries A
Cathay InnovationSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    Taiwania Hive Ventures led the round.

  • Jan 6, 2023

    $4M round led by Chularat Hospital Public Company Limited.

Arincare Filings

Explore SEC and related filing metadata, where available.

Arincare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Arincare's valuation, stock price, and market status.

Is Arincare a public or private company?

Arincare is a private company.

What is the current stock price of Arincare?

Arincare is a private company with no public stock price. No recent secondary market data is available.

How much is Arincare worth (valuation)?

Valuation information for Arincare is not publicly available.

Can I buy Arincare stock?

Arincare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Arincare's last funding round?

Arincare's most recent funding round was Series B Extension on June 3, 2026.

Who are the main investors in Arincare?

Key investors in Arincare include Nexter Ventures, Taiwania Hive Ventures.

Will Arincare IPO soon?

No public IPO plans have been announced for Arincare.

How can I track Arincare secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arincare's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangkok
Employee Range11
Year Founded2015
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?